HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Chatfield-Reed K, Gui S, O'Neill WQ, Teknos TN, et al. Oral Oncol 2020;100:104488.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chatfield-Reed K, Gui S, O'Neill WQ, Teknos TN, et al. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Oral Oncol 2020;100:104488.
PMID: 31835137